Next-Generation Mass Spectrometer Market Expected to Surpass USD $5.24 Billion by 2029, Expanding at 9.9% CAGR

on

Next-Generation Mass Spectrometer Market

 Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends


What Are the Projections for Next-Generation Mass Spectrometer Market Size and CAGR During 2025-2029?
The next-generation mass spectrometer market size has grown rapidly in recent years. It will grow from $3.26 billion in 2024 to $3.60 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growing adoption in pharmaceutical research, rising need for food safety analysis, increasing environmental monitoring applications, expansion of academic proteomics studies, and rising government funding for clinical diagnostics.

The next-generation mass spectrometer market size is expected to see strong growth in the next few years. It will grow to $5.24 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing applications in biotechnology and life sciences, rising prevalence of chronic diseases requiring molecular diagnostics, expansion of forensic and toxicology testing, and increasing regulatory pressure for contaminant testing. Major trends in the forecast period include miniaturized and portable instruments, developments in software and artificial intelligence for data analysis, research and development in proteomics and metabolomics, and automation and integration in high-throughput analytical workflows.

Claim your free report sample now:

What Are the Major Drivers Influencing the Next-Generation Mass Spectrometer Market?
The growing emphasis on personalized medicine is expected to propel the growth of the next-generation mass spectrometer market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare decisions to an individual’s unique genetic, environmental, and lifestyle factors for more effective outcomes. The growing emphasis on personalized medicine is due to the need to provide tailored treatments that improve patient outcomes, reduce side effects, and optimize healthcare efficiency based on individual genetic and lifestyle factors. The next-generation mass spectrometer supports personalized medicine by providing highly precise and comprehensive molecular analysis that helps identify individual biomarkers, monitor therapeutic responses, and guide tailored treatment plans for improved patient outcomes. For instance, in February 2024, according to a report by the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the Food and Drug Administration (FDA), a US-based federal agency, authorized 16 new personalized medicines for rare disease patients, up from six in 2022. Therefore, the growing emphasis on personalized medicine will drive the growth of the next-generation mass spectrometer market.

Which Segment Holds the Largest Share in the Next-Generation Mass Spectrometer Market?
The next-generation mass spectrometer market covered in this report is segmented

1) By Type: Fourier Transform, Linear Ion Trap Mass Spectrometry, Other Types
2) By Application: Pharmaceuticals, Biotechnology, Clinical Diagnostics, Environmental Analysis, Food And Beverage Testing, Forensic Science, Other Applications
3) By End User: Research Laboratories, Academic Institutions, Pharmaceutical Companies, Biotechnology Firms, Clinical Laboratories, Government Agencies

Subsegments:
1) By Fourier Transform Mass Spectrometry: Fourier Transform Ion Cyclotron Resonance (FT-ICR), Fourier Transform Orbitrap Mass Spectrometry, Hybrid FT-MS Systems, High-Resolution Accurate Mass (HRAM) FT-MS
2) By Linear Ion Trap Mass Spectrometry: Quadrupole Ion Trap, Three-Dimensional Linear Ion Trap, Dual-Pressure Linear Ion Trap, Linear Ion Trap-Time Of Flight (LIT-TOF) Hybrid
3) By Other Types: Time-Of-Flight Mass Spectrometry (TOF-MS), Quadrupole Mass Spectrometry, Orbitrap Mass Spectrometry (Non-FT Applications), Magnetic Sector Mass Spectrometry, Ion Mobility Mass Spectrometry, Hybrid Mass Spectrometers

Which Emerging Trends Are Driving the Next-Generation Mass Spectrometer Market?
Major companies operating in the next-generation mass spectrometer market are focusing on the development of highly efficient instruments that enable researchers to analyze complex biological samples with unprecedented precision and speed. These innovations aim to improve biomarker discovery, facilitate early disease detection, and accelerate the development of personalized therapies. For instance, in June 2023, Thermo Fisher Scientific Inc., a US-based clinical research company, launched the Orbitrap Astral mass spectrometer, featuring fast throughput, high sensitivity, and deep proteome coverage, one of the most significant mass spectrometry advancements in 15 years. This next-generation instrument enables researchers to detect previously inaccessible low-abundance proteins by combining ultra-fast scan speeds, exceptional sensitivity, and deep proteome coverage, significantly advancing large-scale proteomic analysis. It also incorporates enhanced ion transmission efficiency, improved dynamic range, and up to four times higher throughput, allowing for faster biomarker discovery, precise quantification, and the development of targeted therapies across a wide range of diseases.

Which Major Companies Are Operating in the Next-Generation Mass Spectrometer Market?
Major companies operating in the next-generation mass spectrometer market are Hitachi Ltd., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd., JEOL Ltd., Rigaku Corporation, LECO Corporation, Hiden Analytical Ltd., Scion Instruments Ltd., MOBILion Systems Inc., Jiangsu Skyray Instrument Co. Ltd., Spacetek Technology Inc., and Hexsor Scientific Ltd.

Get the full next-generation mass spectrometer market report here:

Which Region Is Expected to Lead the Next-Generation Mass Spectrometer Market by 2029?
North America was the largest region in the next-generation mass spectrometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation mass spectrometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company


Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267



Follow Us On:

Comments

Post a Comment